Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Pace

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Archives of Biochemistry and Biophysics|March 4, 2009
Role of conserved F(alpha)-helix residues in the native fold and stability of the kinase-inhibited oxy state of the oxygen-sensing FixL protein from Sinorhizobium melilotiMark F Reynolds, Lindsey Ackley, Alice Blizman, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
The Journal of Infectious Diseases|November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory ExpansionGenevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Frontiers in Immunology|May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNAGenevieve E Martin, Matthew Pace, John P Thornhill, et al.
Frontiers in Immunology|June 21, 2021
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral TherapyGenevieve E Martin, Debattama R Sen, Matthew Pace, et al.
Frontiers in Immunology|September 16, 2022
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruptionMatthew Pace, Ane Ogbe, Jacob Hurst, et al.
Journal of Virus Eradication|October 6, 2021
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approachJasmini Alagaratnam, Wolfgang Stöhr, Jamie Toombs, et al.
African Health Sciences|April 28, 2023
The impact of the COVID-19 pandemic on the Mediterranean region over 18 months: bridging the health outcomes and sustainable development goalsSarah Cuschieri, Elizabeth Grech, Adrienne Gatt, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Archives of Biochemistry and Biophysics|March 4, 2009
Role of conserved F(alpha)-helix residues in the native fold and stability of the kinase-inhibited oxy state of the oxygen-sensing FixL protein from Sinorhizobium melilotiMark F Reynolds, Lindsey Ackley, Alice Blizman, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
The Journal of Infectious Diseases|November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory ExpansionGenevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Frontiers in Immunology|May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNAGenevieve E Martin, Matthew Pace, John P Thornhill, et al.
Frontiers in Immunology|June 21, 2021
Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral TherapyGenevieve E Martin, Debattama R Sen, Matthew Pace, et al.
Frontiers in Immunology|September 16, 2022
Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruptionMatthew Pace, Ane Ogbe, Jacob Hurst, et al.
Journal of Virus Eradication|October 6, 2021
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approachJasmini Alagaratnam, Wolfgang Stöhr, Jamie Toombs, et al.
African Health Sciences|April 28, 2023
The impact of the COVID-19 pandemic on the Mediterranean region over 18 months: bridging the health outcomes and sustainable development goalsSarah Cuschieri, Elizabeth Grech, Adrienne Gatt, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.
Pageof 3